| WUSS |
2026 |
A Weighted Deming Regression SAS Macro |
Jesse Albert Canchola, Brahian Urrego, Natasha Oza |
source |
29 |
| WUSS |
2026 |
Stress Testing Your Findings: E-Values and Quantitative Bias Analysis in SAS |
Mehrnaz Siavoshi |
source |
13 |
| PharmaSUG CN |
2026 |
Handling Missing Data in Analgesia Clinical Trials and Corresponding SAS Implementation |
Jingbo Zhu, Jiehan Zhang |
source |
17 |
| PharmaSUG |
2026 |
A Statistical Programmer-s Guide to Tipping Point Analysis in SAS |
Ang Xu |
source |
9 |
| PharmaSUG |
2026 |
Tipping Point Analysis: An Illustration of Sensitivity Analysis on Non-Administrative Censoring for Progression-Free Survival (PFS) |
Lihui Deng, Kylie Fan, Xiaoting Qin |
source |
7 |
| PharmaSUG |
2026 |
Women Leadership in AI-Driven Clinical Programming: Navigating Intersectionality and Innovation |
Lida Gharibvand |
source |
31 |
| PHUSE US |
2026 |
Advancing Precision Medicine and Regulatory Readiness: Data Harmonisation and Statistical Methods for Companion Diagnostics Bridging Studies |
Ummul Vara Qurratul Ain |
source presentation source |
10 |
| PHUSE US |
2026 |
Bridging Analysis and Strategy: The Transformative Role of Statistical Analysts in Drug Development |
Lingsong Yun |
source presentation source |
17 |
| PHUSE US |
2026 |
Deriving Phantom Records in BDS Datasets To Support the FDA's Standard Safety Figures for Missing Data Analysis |
Guowei Wu, Ruchitbhai Patel |
source presentation source |
6 |
| PHUSE US |
2026 |
Framework for Incorporating Estimands within the Statistical Analysis Plan |
Inderjeet Arora |
source presentation source |
9 |
| PHUSE US |
2026 |
Is Complexity Worth It? A Case Study Comparing Multiple Imputation Strategies |
Elnaz Ghadimi, David Bushnell |
source poster source |
4 |
| PHUSE APAC |
2026 |
Advancing Clinical Trial Analysis with Trimmed Means: Estimands, Intercurrent Events, and Regulatory Alignment |
Prasanth Palanisamy |
source presentation source |
9 |
| PHUSE APAC |
2026 |
Beyond Log-Rank: Advanced Survival Analysis for Non-Proportional Hazards in Oncology Trials |
Jagdish Nikam |
source poster source |
7 |
| PHUSE APAC |
2026 |
Enhancing Interpretation of Propensity Score Matching through Advanced Data Visualization in Real-World Studies |
KiranKumar Vyas, Umayal Annamalai |
source presentation source |
7 |
| PHUSE APAC |
2026 |
External Comparator Studies in the Era of Real-World Data |
Vishal Goriya, Anshul Sinha, Gerd Rippin |
source presentation source |
5 |
| PHUSE APAC |
2026 |
Invisible Influences: Estimands, Assumptions and Sensitivity in Inflammation & Immunologic Trial Interpretation |
Sukanya Erramachetty Subramanyam |
source presentation source |
8 |
| PHUSE APAC |
2026 |
Leveraging Historical Control Data Through Adaptive Bayesian Hierarchical Models |
Ajoy Mukhopadhyay, Debarghya Baul |
source presentation source |
12 |
| PHUSE APAC |
2026 |
Machine Learning Algorithms to Explore the Relationship Between Primary Obsessive-Compulsive Disorder (OCD) and Co-morbid Depression Symptoms |
Ajay Kumar Singh, Sabyasachi Mukherjee |
source presentation source |
12 |
| PHUSE APAC |
2026 |
One-year Urate-Lowering Therapy Adherence and Risk of Major Osteoporotic Fracture: A Target Trial Emulation Study |
Seong Jun Byun |
source poster source |
5 |
| PHUSE APAC |
2026 |
Tipping Point Analysis in R and SAS: A Comparative Approach to Handling Missing Data in Clinical Research |
Sushil Kale, Jeet Agrawal |
source poster source |
7 |
| PHUSE EU |
2025 |
Evaluating the Use of Real-World Data (RWD) as a Synthetic Control Group: A Statistical Approach |
Vasiliki Economou, Dimitrios Kounelis |
source poster source |
17 |
| PHUSE EU |
2025 |
Mind the Gap: Imputing Missing Dosing Times in QD & BID Regimens Using ADPPK Guidelines |
Aschwin van der Giesen, Gerly van der Vleuten |
source presentation source |
8 |
| PHUSE EU |
2025 |
Our Journey in Integrating External Control Arms (ECAs) and Real-World Data (RWD) for Rare Disease Trials |
Cyril Sombrin, Gautham Selvaraj |
source poster source |
4 |
| MWSUG |
2025 |
Mind the Gaps: Automating Multiple Imputation in Clinical Trial Workflows [presentation] |
Crisa Chen, Jiangang Cai |
source |
30 |
| WUSS |
2025 |
FDA says, Do the Allowable Total Difference Zone: A Method Comparison using the ATDzone SAS Macro |
Jesse Albert Canchola, Natasha Oza |
source |
22 |
| WUSS |
2025 |
Inter-reader Variability and Reader Weighting in Diagnostic Accuracy Studies using the SAS System |
Jesse Albert Canchola, Monica Vasquez, Payam Ahmadi |
source |
22 |
| PharmaSUG |
2025 |
Handling Missing Data in External Control Arms: Best Practices, Recommendations, and SAS Code Examples |
Yutong Zhang |
source |
6 |
| PharmaSUG |
2025 |
Multiple Imputation Techniques in the Context of ADaM Datasets |
Shunbing Zhao, Linping Li |
source |
11 |
| PharmaSUG |
2025 |
Practical considerations for Intercurrent Events and Multiple Imputation |
David Bushnell |
source |
6 |
| PharmaSUG |
2025 |
Sensitivity Analysis for Overall Survival |
Binal Mehta, Patel Mukesh |
source |
13 |
| PHUSE US |
2025 |
Transforming Clinical Trials: Leveraging Bayesian Statistics in Innovative Trial Design, Analysis, Applications and Navigating Challenges |
Jaskaran Singh Saini |
source presentation source |
11 |
| MWSUG |
2024 |
The Premium Pricing Dilemma [presentation] |
Sai Suresh Marreddy, Kusuma Lanka |
source |
20 |
| PHUSE EU |
2024 |
Artificial Intelligence Potential Use Cases in Clinical Data Engineering |
Deepak Pakalapati, Mounika Pillamarapu |
source presentation source |
8 |
| PHUSE EU |
2024 |
Innovation of Causal Inferential Frameworks for Biostatistics in Real-World Data and Evidence |
Anwesha Roy |
source poster source |
8 |
| PHUSE EU |
2024 |
Unveiling the Tipping Point: An In-depth Analysis |
Varsha Mithun Patil, Ephicacy Lifescience |
source presentation source |
8 |
| WUSS |
2024 |
Developing a SAS Macro for ISNI: Assessing Missing Data Sensitivity Beyond MAR Assumptions |
Bocheng Jing, L. Grisell Diaz-Ramirez, W. John Boscardin |
source |
16 |
| PharmaSUG CN |
2024 |
E9(R1) Program Practice and Its Application in Sensitivity Analysis |
Dawei Jiao |
source |
6 |
| PharmaSUG CN |
2024 |
Implementing Statistical Methods in Companion Diagnostic: A Case Study in NSCLC |
Danxia Hu, Mandy Gao, Jianyong Tong |
source |
10 |
| PharmaSUG |
2024 |
Bayesian Methods in Survival Analysis: Enhancing Insights in Clinical Research |
Vadym Kalinichenko |
source |
11 |
| PharmaSUG |
2024 |
Submitting Patient-Reported Outcome Data in Cancer Clinical Trials - Guidance for Industry Technical Specifications Document [presentation] |
Flora Mulkey |
source |
48 |
| PHUSE US |
2024 |
EOSS_MMRM V1.0: A Shiny Application for Estimand-Oriented Sample Size and Power Simulation Using MMRM Modelling |
Xiaoli Kong, Jing Dai |
source presentation source |
8 |
| PHUSE EU |
2023 |
Efficacy Analyses with Imputations: Methods, Limitations and Lessons Learned |
Amine Khemiri |
source presentation source |
3 |
| PHUSE EU |
2023 |
Handling Missing Data in Exploratory Analyses Using RWD: 'Collect the Data You Love or Love the Data You Get' - A Case Study [presentation] |
Jean-Marc Ferran |
source |
22 |
| SESUG |
2023 |
Forecasting Goals for Student Success Metrics in Accountability Performance Reporting using SAS Visual Analytics |
Xiaoying Liu, Hennadii Balashov |
source |
9 |
| SESUG |
2023 |
Longitudinal Analysis of Marital Therapy's Impact on Intimacy in Heterosexual Couples |
Yaa Awuah, Mostafa Zahed |
source |
19 |
| PharmaSUG |
2023 |
ADaM Design and Programming Standardization for Oncology Efficacy Endpoints Based on RECIST 1.1 |
Ellen (Zihui) Lin, Matt Ness, Yinghui Wang |
source |
9 |
| PharmaSUG |
2023 |
Application of Tipping Point Analysis in Clinical Trials using the Multiple Imputation Procedure in SAS |
Yunxia Sui, Xianwei Bu, Yuanyuan Duan, Yihan Li, Xin Wang |
source |
12 |
| PharmaSUG |
2023 |
Sensitivity Analysis for Missing Data Using Control-based Pattern Imputation |
Jun Feng, Jingmin Liu |
source |
7 |
| PharmaSUG |
2023 |
Statistical Considerations and Methods for Handling Missing Outcome Data in Clinical Trials During the Era of COVID-19 |
Xi Qian, Chengfei Lu |
source |
11 |
| PHUSE US |
2023 |
Admiralonco - The Cross-Company R Package for Oncology Admirers [presentation] |
Neharika Sharma, Matt Marino |
source video |
11 |
| PHUSE EU |
2022 |
Advanced SAS techniques to Generate Automated Topline RTF Reports - Used Daily by PMs |
Mizan Alam |
source presentation source |
15 |
| SESUG |
2022 |
Standardized, Customized or Both? Defining and Implementing (MedDRA) Queries in ADaM Data Sets |
Richann J. Watson, Karl Miller |
source |
7 |
| WUSS |
2022 |
Standardized, Customized or Both? Defining and Implementing (MedDRA) Queries in ADaM Data Sets |
Richann J. Watson, Karl Miller |
source |
7 |
| PHUSE US |
2022 |
Pan-pharma Industry Collaboration - New Horizon, Success Stories [presentation] |
Tadeusz Lewandowski |
source video |
21 |
| PHUSE US |
2022 |
Reassure Your Assumptions Using Sensitivity Analysis [presentation] |
Vadym Kalinichenko |
source video |
29 |
| PHUSE EU |
2021 |
Let's ROC: An Empirical Approach to Confidence Intervals of Receiver-Operator Characteristic Curves [presentation] |
Alexander Ullmann, Sanna Ström |
source video |
41 |
| PHUSE EU |
2021 |
The Application of Pattern Mixture Models and Tipping Point Analysis in Clinical Trials Involving Multiple Imputations [poster] |
Anastasiia-Narmina Fataliieva, Daria Shamaida |
source video |
1 |
| PHUSE US |
2021 |
Central Statistical False Positives - Predicting True Signals with Machine Learning [presentation] |
Dorothea Ugi |
source video |
24 |
| PHUSE EU |
2020 |
Addressing Industry Disruptions in Clinical Trials with Real-world Data in Lieu of COVID-19 [presentation] |
Sherrine Eid, Stijn Rogiers |
source video |
30 |
| PHUSE EU |
2020 |
Incomplete Data in Longitudinal Studies: Continuous and Dichotomous Outcome [presentation] |
Ana Grecu |
source video |
20 |
| PHUSE EU |
2020 |
MI FOR MI, OR HOW TO HANDLE MISSING INFORMATION WITH MULTIPLE IMPUTATION |
Daria Shamaida |
source video presentation source |
8 |
| SGF |
2020 |
Turning the Crank. A Simulation of Optimizing Model Retraining |
David R. Duling |
source |
17 |
| PharmaSUG |
2020 |
Principal Stratum strategy for handle intercurrent events: a causal estimand to avoid biased estimates |
Andrea Nizzardo, Giovanni Marino Merlo, Simona Scartoni |
source |
13 |
| PHUSE US |
2020 |
Efficacy ADaMs in Oncology - Step by Step (Dataset by Dataset) |
Ilya Krivelevich, Ran Xie |
source presentation source |
8 |
| PHUSE US |
2020 |
Handling Missing Data in Clinical Trials: Techniques and Methods |
Pennidhi Karlakunta, Naveen Kommuru |
source presentation source |
9 |
| PHUSE US |
2020 |
Interactive Real-world Data Analysis Using Machine Learning Algorithms |
James J. Kim |
source poster source |
5 |
| PHUSE EU |
2019 |
Optimise PRO Data Analysis with an Interactive Approach |
Tadeusz Lewandowski |
source presentation source |
9 |
| PharmaSUG |
2019 |
SAS V9.4 MNAR statement for multiple imputations for missing not at random in longitudinal clinical trials |
Lingling Li |
source |
11 |
| SGF |
2019 |
Using SAS to Validate Prediction Models |
Xiaoting Wu, Chang He, Donald S. Likosky |
source |
9 |
| PHUSE US |
2019 |
Optimize PRO Data Analysis with an Interactive Approach |
Xiangyun Wang, Elisabeth Piault-Louis |
source presentation source |
8 |
| MWSUG |
2018 |
Using SAS to Validate Clinical Prediction Models |
Xiaoting Wu, Chang He, Donald S. Likosky |
|
8 |
| WUSS |
2018 |
How sensitive is your analysis? A case study on addressing it at ADaM level. |
Bhargav Koduru, Balavenkata Pitchuka |
source |
7 |
| PHUSE US |
2018 |
Assuring Data Integrity and Data Quality in Sponsor Submissions |
Paul Schuette |
source presentation source |
5 |
| PharmaSUG |
2018 |
Improved Transparency in Key Operational Decisions in Real World Evidence |
Rebecca Levin, Irene Cosmatos |
source |
11 |
| SGF |
2018 |
!WRONG PAPER FIEL - WAITING for FIX! |
Nikki M. Carroll |
source |
9 |
| SGF |
2018 |
Application of Propensity Score Models in Observational Studies |
Nikki M. Carroll |
source |
9 |
| PharmaSUG |
2017 |
Standardized, Customized or Both? Defining and Implementing (MedDRA) Queries in ADaM Data Sets |
Richann J. Watson, Karl Miller |
source |
7 |
| SGF |
2017 |
Optimizing Your Optimizations by Maximizing the Financial and Business Impacts of SAS Marketing Optimization Scenarios |
Erin McCarthy |
source |
14 |
| MWSUG |
2016 |
An Animated Guide: Insights into the Logic of the ROC Curve |
Russell M. Lavery |
|
8 |
| MWSUG |
2016 |
Identifying the factors responsible for loan defaults and classification of customers using SAS Enterprise Miner |
Juhi Bhargava, Prashanth Reddy Musuku |
|
13 |
| WUSS |
2016 |
An Animated Guide: Insights into the Logic of the ROC Curve |
Russell M. Lavery |
source |
8 |
| WUSS |
2016 |
MIghty PROC MI to the rescue! |
Cynthia Alvarez |
source |
10 |
| SGF |
2016 |
Application of Data Mining Techniques in Improving Breast Cancer Diagnosis |
Josephine Akosa |
source presentation |
10 |
| SGF |
2016 |
Credit Risk Modeling in a New Era |
Wei Chen, Martim Rocha, Jimmy Skoglund |
source |
16 |
| SGF |
2016 |
Simultaneous Forecasts of Multiple Interrelated Time Series with Markov Chain Model |
Gongwei Chen |
source |
11 |
| PHUSE EU |
2015 |
Facing Your Fear of the Unknown - Handling Missing Data |
Amanda Reilly |
source presentation source |
7 |
| SESUG |
2015 |
Regulatory Stress Testing - A Manageable Process with SAS |
Wei Chen, John Pechacek, Erik Leaver, Shannon Clark |
source |
12 |
| SGF |
2015 |
Random vs. Fixed Effects: Which Technique More Effectively Addresses Selection Bias in Observational Studies |
Jessica Navratil-Strawn, Stephen Hartley, Ronald J. Ozminkowski |
source zip |
8 |
| SGF |
2015 |
Regulatory Stress Testing - A Manageable Process with SAS |
Wei Chen, John Pechacek, Erik Leaver, Shannon Clark |
source |
12 |
| SGF |
2015 |
Time Series Modeling and Forecasting--An Application to Stress-Test Banks |
Ania Supady |
source |
13 |
| PHUSE EU |
2014 |
Cost-Effectiveness in Hospitals Using SAS |
Ilias Pyrnokokis |
source presentation source |
8 |
| PharmaSUG CN |
2014 |
Design and Construct Efficacy Analysis Datasets in Later Phase Oncology Study |
Huadan Li, Changhong Shi |
|
9 |
| WUSS |
2014 |
Markov Chain Model Forecast for Interrelated Time Series Data Using SAS/IML |
Gongwei Chen |
source |
10 |
| SGF |
2014 |
Sensitivity Analysis in Multiple Imputation for Missing Data |
Yang Yuan |
source |
12 |
| SGF |
2014 |
Using SAS to Examine Internal Consistency and to Develop Community Engagement Scores |
Renee Gennarelli, Melody S. Goodman |
source |
10 |
| PHUSE EU |
2013 |
Economic Evaluation in Clinical Trials. You Can Do it with SAS |
Artur Usov |
source presentation source |
12 |
| PHUSE EU |
2013 |
Efficacy Endpoints in Oncology |
Angelo Tinazzi |
source |
9 |
| PHUSE EU |
2013 |
Orphan Indication Therapies: Programming for a Patient Population without Options [presentation] |
Todd Case |
source |
24 |
| WUSS |
2012 |
Sensitivity analysis of nonlinear mixed-effects models for longitudinal data that areincomplete |
Shelley A. Blozis |
source |
6 |
| SGF |
2012 |
Propensity Score Analysis and Assessment of Propensity Score Approaches Using SAS Procedures |
Rheta E. Lanehart, Patricia Rodríguez de Gil, Eun Sook Kim, Aarti P. Bellara, Jeffrey D. Kromrey, Reginald Lee |
source |
11 |
| WUSS |
2011 |
Turbocharging Your Microsoft Office Environment with version 4.3 of the SAS Add-In for Microsoft Office |
Kevin Bickford |
source |
21 |
| PharmaSUG |
2011 |
Cost-Effectiveness Of Primary PCI At Hospitals Without Onsite CaABG |
Pedro Ramos |
source |
21 |
| PharmaSUG |
2011 |
Implementation of Pattern-Mixture Models Using Standard SAS/STAT Procedures |
Bohdana Ratitch, Michael O'Kelly |
source |
10 |
| SGF |
2011 |
Enrich your SAS Reporting with SAS Predictive Analytics |
Rob Craige |
source |
15 |
| SGF |
2011 |
Turbocharging Your Microsoft Office Environment with SAS Add-In for Microsoft Office 4.3 |
Anand V. Chitale |
source |
21 |
| NESUG |
2010 |
A SAS Application to Identify and Evaluate Outliers |
Richard Hendra, Paulette W. Staum |
|
16 |
| MWSUG |
2010 |
Ad Hoc and Statistical Model Visualization Using JMP, SAS, and Excel |
Jon T. Weisz |
|
10 |
| SESUG |
2010 |
Ad Hoc and Statistical Model Visualization Using JMP, SAS, and Excel |
Jon T. Weisz |
source |
10 |
| SGF |
2010 |
Ad Hoc and Statistical Model Visualization Using JMP, SAS, and Excel |
Jon T. Weisz |
source |
10 |
| SGF |
2009 |
Bayesian Modeling Using the MCMC Procedure |
Fang K. Chen |
source |
22 |
| SGF |
2009 |
Reject Inference Techniques Implemented in Credit Scoring for SAS Enterprise Miner |
Billie Anderson, Susan Haller, Naeem Siddiqi |
source |
11 |
| PharmaSUG |
2008 |
Facilitate Statistical Analysis with Automatic Collapsing of Small Size Strata |
Sunil Kumar Gupta, Linfeng Xu, Thousand Oaks |
|
12 |
| PharmaSUG |
2007 |
A Review of Propensity Score Application in Healthcare Outcome and Epidemiology |
Guiping Yang |
|
24 |
| SCSUG |
2004 |
A SAS/OR Primer on Using PROC LP |
Michael E. Salassi |
|
14 |
| SCSUG |
2004 |
Designing the Optimal File Linkage Algorithm (OFLA) [ Poster ] |
Tsai Mei Lin |
|
14 |
| SEUGI |
2003 |
SAS Human Capital Management [presentation] |
Carolyn Cobb |
source |
30 |
| SEUGI |
2003 |
SAS Marketing Optimization [presentation] |
Neil Hayward |
source |
28 |
| SEUGI |
2002 |
The problem of treasurey portfolio optimisation [presentation] |
Alexey Kulemin, Vasily Konuzin, Vasily Sorokoumov, Victor Kulyshev |
source |
52 |
| SEUGI |
2001 |
A System for Monitoring and Analysing Legal Actions [presentation] |
Roberto Noceta |
source |
18 |
| SEUGI |
2000 |
Credit Risk Measurement for a Bank Loans Portfolio |
Emiliano Laruccia, Valter Lazzari |
source |
11 |
| SEUGI |
2000 |
Snapshot of the Procurement Environment - Readiness Check - The Basis for Optimisation at Franke Group [presentation] |
Beat Waldmeier, Stefano Musso |
source |
41 |
| SUGI |
2000 |
Design and Analysis of Cancer Control Studies via the SAS System |
Jeff A. Sloan, Charles L. Loprinzi, Paul J. Novotny |
source |
10 |
| NESUG |
1999 |
Applying Familiar Non-Parametric Tests to Evaluation of Neural Network Inputs |
Susan B. Garavaglia |
|
10 |
| SEUGI |
1998 |
The methodogical integration between business and technology skills in a data warehouse [presentation] |
Daniele Vanzanelli |
source |
24 |
| NESUG |
1997 |
Using Logistic Regression to Test for Interaction in the Presence of Zero Cells |
Lisa Suchower |
|
10 |
| SEUGI |
1996 |
Marketing Information System |
UNKNOWN |
source |
22 |
| SUGI |
1993 |
A Fuzzy Clustering Approach in Support of Identifying Influential Observations and the Computation of Multiple Outlier Diagnostics |
Konstantinos Triantis, Ritu Puri, William L. Seaver |
source |
6 |
| SUGI |
1992 |
Managing Time and Resources: Enterprisewide Project Management |
Laurie Rose |
source |
4 |
| SUGI |
1992 |
Optimal Tax Strategies for Small Businesses and Professional Practices |
Janet R. Gibley, Raymond A. Gibley |
source |
3 |
| SEUGI |
1990 |
Using the SAS System as an Executive Information System |
Claudia Cavedon |
source |
6 |
| SUGI |
1990 |
Polychlorinated Biphenyls Information Management and Modeling System for the Unsaturated Soil Zone |
Jing-Yea Yang, Shi-Tao Yeh, Frederick Bopp III |
source |
6 |
| SUGI |
1986 |
Progress Towards SAS/OR Software for the Microcomputer |
Marc-David Cohen |
source |
9 |
| SUGI |
1985 |
A SAS Procedure for Evaluating the Performance of Token Ring Local Area Networks |
Richard L. Gimarc, James H. Smith |
source |
8 |
| SUGI |
1983 |
Introduction to Linear Programming with SAS |
Marc-David Cohen |
source |
8 |
| SUGI |
1982 |
A Data Mangement and Forecasting System for the Non-Data Processing User.. |
Janet S. Bridgers, Kenneth A. Sprinkle |
source |
6 |